Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil

Detalhes bibliográficos
Autor(a) principal: Scaraveli,Natália Gazzoni
Data de Publicação: 2011
Outros Autores: Passos,Ana Maria, Voigt,Andréia Royer, Livramento,Andréa do, Tonial,Gabriela, Treitinger,Aricio, Spada,Celso
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Cadernos de Saúde Pública
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2011000400014
Resumo: This study was carried out to determine the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) markers among adolescents aged between 10 and 16 years old, who are elementary school students in the city of Chapecó, Santa Catarina State, Brazil. The study involved a cross-sectional survey that included 418 volunteers, from March to July, 2008. Serology comprised HBsAg, anti-HBc, anti-HBs and anti-HCV. Tests were performed using automated Microparticle Enzyme Immunosorbant Assay (Abbott, AxSYM System, Wiesbaden, Germany). The prevalence of HBsAg was found to be 0.2% (95%CI: 0.0-1.3), and the prevalence of anti-HBc was found to be 1.4% (95%CI: 0.5-3.1). Regarding anti-HBs, 48.6% had titers greater than 10UI/L. None of the volunteers presented reactive results for anti-HCV. This study showed a low prevalence of HBV and HCV markers of infection and a great number of volunteers immunized against HBV. Finally this study shows the importance of proper health campaigns and policies in reducing those prevalences.
id FIOCRUZ-5_899de258b631dd5edd6ed95f39852ce8
oai_identifier_str oai:scielo:S0102-311X2011000400014
network_acronym_str FIOCRUZ-5
network_name_str Cadernos de Saúde Pública
repository_id_str
spelling Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern BrazilHepatitis BHepatitis CVaccinationSeroepidemiologic StudiesThis study was carried out to determine the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) markers among adolescents aged between 10 and 16 years old, who are elementary school students in the city of Chapecó, Santa Catarina State, Brazil. The study involved a cross-sectional survey that included 418 volunteers, from March to July, 2008. Serology comprised HBsAg, anti-HBc, anti-HBs and anti-HCV. Tests were performed using automated Microparticle Enzyme Immunosorbant Assay (Abbott, AxSYM System, Wiesbaden, Germany). The prevalence of HBsAg was found to be 0.2% (95%CI: 0.0-1.3), and the prevalence of anti-HBc was found to be 1.4% (95%CI: 0.5-3.1). Regarding anti-HBs, 48.6% had titers greater than 10UI/L. None of the volunteers presented reactive results for anti-HCV. This study showed a low prevalence of HBV and HCV markers of infection and a great number of volunteers immunized against HBV. Finally this study shows the importance of proper health campaigns and policies in reducing those prevalences.Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz2011-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2011000400014Cadernos de Saúde Pública v.27 n.4 2011reponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZ10.1590/S0102-311X2011000400014info:eu-repo/semantics/openAccessScaraveli,Natália GazzoniPassos,Ana MariaVoigt,Andréia RoyerLivramento,Andréa doTonial,GabrielaTreitinger,AricioSpada,Celsoeng2011-05-09T00:00:00Zoai:scielo:S0102-311X2011000400014Revistahttp://cadernos.ensp.fiocruz.br/csp/https://old.scielo.br/oai/scielo-oai.phpcadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2011-05-09T00:00Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil
title Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil
spellingShingle Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil
Scaraveli,Natália Gazzoni
Hepatitis B
Hepatitis C
Vaccination
Seroepidemiologic Studies
title_short Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil
title_full Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil
title_fullStr Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil
title_full_unstemmed Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil
title_sort Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil
author Scaraveli,Natália Gazzoni
author_facet Scaraveli,Natália Gazzoni
Passos,Ana Maria
Voigt,Andréia Royer
Livramento,Andréa do
Tonial,Gabriela
Treitinger,Aricio
Spada,Celso
author_role author
author2 Passos,Ana Maria
Voigt,Andréia Royer
Livramento,Andréa do
Tonial,Gabriela
Treitinger,Aricio
Spada,Celso
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Scaraveli,Natália Gazzoni
Passos,Ana Maria
Voigt,Andréia Royer
Livramento,Andréa do
Tonial,Gabriela
Treitinger,Aricio
Spada,Celso
dc.subject.por.fl_str_mv Hepatitis B
Hepatitis C
Vaccination
Seroepidemiologic Studies
topic Hepatitis B
Hepatitis C
Vaccination
Seroepidemiologic Studies
description This study was carried out to determine the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) markers among adolescents aged between 10 and 16 years old, who are elementary school students in the city of Chapecó, Santa Catarina State, Brazil. The study involved a cross-sectional survey that included 418 volunteers, from March to July, 2008. Serology comprised HBsAg, anti-HBc, anti-HBs and anti-HCV. Tests were performed using automated Microparticle Enzyme Immunosorbant Assay (Abbott, AxSYM System, Wiesbaden, Germany). The prevalence of HBsAg was found to be 0.2% (95%CI: 0.0-1.3), and the prevalence of anti-HBc was found to be 1.4% (95%CI: 0.5-3.1). Regarding anti-HBs, 48.6% had titers greater than 10UI/L. None of the volunteers presented reactive results for anti-HCV. This study showed a low prevalence of HBV and HCV markers of infection and a great number of volunteers immunized against HBV. Finally this study shows the importance of proper health campaigns and policies in reducing those prevalences.
publishDate 2011
dc.date.none.fl_str_mv 2011-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2011000400014
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2011000400014
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0102-311X2011000400014
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz
publisher.none.fl_str_mv Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz
dc.source.none.fl_str_mv Cadernos de Saúde Pública v.27 n.4 2011
reponame:Cadernos de Saúde Pública
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Cadernos de Saúde Pública
collection Cadernos de Saúde Pública
repository.name.fl_str_mv Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br
_version_ 1754115731152175104